US · Healthcare · Medical Devices
EPS came in at 1.55 against a street estimate of 1.54 — a beat of 0.6%.
Analysts rate Medtronic PLC a buy (17 buy, 13 hold, 2 sell out of 32) with an average price target of $98.44.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.84% |
| Vanguard Capital Management, LLC | 6.51% |
| State Street Corp | 4.82% |
| JPMorgan Chase & Co | 3.98% |
| Capital Research Global Investors | 3.28% |
| Vanguard Portfolio Management, LLC | 2.61% |
| Geode Capital Management, LLC | 2.24% |
| Bank of America Corp | 2.03% |
| Document | Date |
|---|---|
| Annual report FY2026 | 2026-06-18 |
| Results announced · Q2 2026 | 2026-06-03 |
| Board / officer change · Q2 2026 | 2026-05-18 |
| Reg FD disclosure · Q2 2026 | 2026-04-27 |
| Reg FD disclosure · Q1 2026 | 2026-03-24 |
| Quarterly report · Q1 2026 | 2026-02-24 |
| Quarterly report · Q4 2025 | 2025-11-25 |
| Quarterly report · Q3 2025 | 2025-08-26 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.72 / share ex-date Jun 26, 2026 · pay Jul 17, 2026 | 2026-06-26 |
| Dividend | $0.71 / share ex-date Mar 27, 2026 · pay Apr 17, 2026 | 2026-03-27 |
| Dividend | $0.71 / share ex-date Dec 26, 2025 · pay Jan 16, 2026 | 2025-12-26 |
| Dividend | $0.71 / share ex-date Sep 26, 2025 · pay Oct 17, 2025 | 2025-09-26 |
| Announcement | Date |
|---|---|
| FY2026 non-GAAP EPS guidance lowered due to MiniMed-related impacts Medtronic's subsidiary MiniMed received FDA clearance for the MiniMed Flex, a smartphone-controlled insulin pump, several months ahead of schedule—good news for product launch timing. Howeve | 2026-03-24 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Medtronic PLC — free to start.
Google PlayApp StoreData updated 2026-08-05.